Home > Find a Provider > Ritesh Parajuli, MD

UCI Health will see you now: Welcome to our new co-workers and patients from Fountain Valley, Lakewood, Los Alamitos and Placentia Linda! 

« Return to Search
Ritesh Parajuli, MD

Ritesh Parajuli, MD

Specialties

Hematology-Oncology

MyChart patient portal offers a convenient and secure way to manage your healthcare online. Use MyChart to schedule appointments, request prescription renewals, send messages to your care team and more.
Access MyChart
Certifications
  • American Board of Internal Medicine, Medical Oncology [Internal Medicine]
Language
  • English
  • Hindi
Gender
Male
Medical School
Manipal College of Medical Sciences, Pokhara, Nepal
Residency
Rosalind Franklin University of Medicine and Sciences, Chicago, Ill.Internal Residency
Fellowship
University of Miami Sylvester Comprehensive Cancer Center and Jackson Memorial Hospital, Miami, Fla.Hematology/Oncology
Professional Positions
  • Assistant Professor — Division of Hematology/Oncology, Department of Medicine, UCI School of Medicine
  • Medical Director — Chemotherapy Infusion Center, Chao Family Comprehensive Cancer Center
  • Co-chair — Breast Cancer Disease-oriented Team, Chao Family Comprehensive Cancer Center
  • Member — UCI Institutional Review Board
  • Member — Grant Review Committee, Institute for Clinical and Translational Science, UC Irvine 
More Information

Dr. Ritesh Parajuli is a UCI Health medical oncologist who specializes in the management of patients with breast cancer.

Parajuli earned his medical degree at Manipal College of Medical Sciences in Nepal, followed by a residency in internal medicine at Rosalind Franklin University of Medicine and Science in Chicago, Ill. He also completed a fellowship in hematology and oncology at the University of Miami Sylvester Comprehensive Cancer Center and Jackson Memorial Hospital, Miami, Fla.

A translational researcher, Parajuli is focused on integrating liquid biopsy biomarkers that have prognostic and predictive implications for the management of breast cancer patients. These biomarkers include circulating tumor cells, circulating tumor DNA and circulating cancer-associated fibroblasts.

Parajuli is co-leader of the Chao Family Comprehensive Cancer Center’s breast disease team, a multidisciplinary group that develops new clinical trial concepts and fosters the translation of discoveries into clinical treatments. He also is the principal investigator on a variety of breast cancer clinical trials, the author or co-author of dozens of published research papers, and recipient of many intramural and extramural research grants.

Parajuli, who serves as medical director of chemotherapy infusion, sees patients at the UCI Health Chao Family Comprehensive Cancer Center in Orange.

UCI Health Chao Family Comprehensive Cancer Center
101 The City Drive South, Building 23
Orange, CA 92868
Phone: 714-456-8000
Fax: 855-211-3729